1
|
Francke W, Mackenroth W, Schroder W, Schulz S, Tengö J, Engels E, Engels W, Kittmann R, Schneider D. Identification of Cyclic Enolethers from Insects: Alkyldihydropyranes from Bees and AIkyldihydro-4H-pyran-4-ones from a Male Moth*. ACTA ACUST UNITED AC 2014. [DOI: 10.1515/znc-1985-1-229] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
Abstract
Mass spectrometric fragmentation patterns of alkyl-3,4-dihydro-2H-pyranes and alkyl-2,3-dihydro-4H-pyran-4-ones are described. Through GC/MS analyses, respective compounds showing unbranched carbon skeletons are identified for the first time as volatile signals of social and solitary bees and of the male moth Hepialus hecta L.
Collapse
Affiliation(s)
- W. Francke
- Institut für Organische Chemie der Universitat, Martin-Luther-King-Platz 6, D-2000 Hamburg 13
| | - W. Mackenroth
- Institut für Organische Chemie der Universitat, Martin-Luther-King-Platz 6, D-2000 Hamburg 13
| | - W. Schroder
- Institut für Organische Chemie der Universitat, Martin-Luther-King-Platz 6, D-2000 Hamburg 13
| | - S. Schulz
- Institut für Organische Chemie der Universitat, Martin-Luther-King-Platz 6, D-2000 Hamburg 13
| | - J. Tengö
- Ecological Station, Uppsala University, S-38600 Färjestaden
| | - E. Engels
- Institut für Biologie III (Zoologie) der Universitat, Auf der Morgenstelle 28. D-7400 Tubingen
| | - W. Engels
- Institut für Biologie III (Zoologie) der Universitat, Auf der Morgenstelle 28. D-7400 Tubingen
| | - R. Kittmann
- Max-Planck-Institut für Verhaltensphysiologie, D-8131 Seewiesen
| | - D. Schneider
- Max-Planck-Institut für Verhaltensphysiologie, D-8131 Seewiesen
| |
Collapse
|
2
|
Garg M, Quick A, Depond W, Schroder W, Chowdhry S, Spertus J. Native aortic valve tissue systemic embolization complicating bacterial endocarditis. Clin Cardiol 2009; 24:166-8. [PMID: 11214748 PMCID: PMC6655108 DOI: 10.1002/clc.4960240213] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
Abstract
Systemic embolic events are known complications of bacterial endocarditis. Embolization of prosthetic valves has previously been reported in the literature. We report a case of embolization of native aortic valve tissue to the popliteal artery as the presenting event in a patient with subacute bacterial endocarditis. To our knowledge, this rare complication has not been previously reported.
Collapse
Affiliation(s)
- M Garg
- Department of Cardiology, Truman Medical Center, University of Missouri-Kansas City School of Medicine, 64108, USA
| | | | | | | | | | | |
Collapse
|
3
|
Schroder W. Similar Histological Patterns in a Bilateral Malignant Teratoma of the Ovary and a Previous Retinoblastoma in a Girl. Oncol Res Treat 2009. [DOI: 10.1159/000217021] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
|
4
|
Schroder W, Campone M, Abadie S, Witteveen P, Viens P, Jalava T, Palacay-Radona M, Bilic S, Laurent D, Du Bois A. A phase IB, open label, safety and pharmacokinetic (PK) study of escalating doses of PTK787/ZK 222584 (PTK/ZK) in combination with paclitaxel and carboplatin in patients (Pts) with stage IC to IV epithelial ovarian cancer (EOC). J Clin Oncol 2006. [DOI: 10.1200/jco.2006.24.18_suppl.5075] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
5075 Background: Vascular endothelial growth factors (VEGFs) and VEGF receptors (VEGFRs) are important mediators of tumor growth and metastasis and their expression is associated with poor prognosis in EOC. PTK/ZK is a novel, oral, angiogenesis and lymphangiogenesis inhibitor that blocks tyrosine kinase signaling from all known VEGFRs. Methods: An open label, multicenter, phase IB dose escalation study evaluating PTK/ZK with chemotherapy as first line therapy in Pts with stage IC to IV EOC. Maximum tolerated dose (MTD) and dose limiting toxicity (DLT) of PTK/ZK were assessed; PK of PTK/ZK, carboplatin and paclitaxel was characterized. Paclitaxel was administered as a 3-hour infusion on day 1 of each 21-day cycle at a dose of 175 mg/m2. Carboplatin was given immediately after paclitaxel as a 30-min IV infusion to AUC of 5 mg min/mL. PTK/ZK was given once daily from day 3 to day 21 of each chemotherapy cycle. Cohorts of 3 to 6 Pts received doses of PTK/ZK at 250, 500, 750, 1000 or 1250 mg/day. Dose expansion in 21 additional Pts was conducted with 1250 mg/day without reaching MTD. After completion of chemotherapy, PTK/ZK was given continuously until disease progression. PK samples were collected in cycle 1 (without PTK/ZK) and cycle 2 (after PTK/ZK pre-treatment). Results: 42 Pts were enrolled. To date 39 Pts are evaluated for safety, 19 Pts for DLT, 35 Pts for PK and 21 Pts with residual disease for tumor response. No DLTs were reported. The most frequently observed grade 3/4 toxicity was neutropenia (31%), leucopenia (18%) and hypertension (10%). PTK/ZK did not aggravate chemotherapy related side effects. To date 67% of Pts had achieved CR/PR, 9% SD, 5% PD and 19% UNK. PTK/ZK exposure at steady state was similar in cycle 1 and 2. PTK/ZK had no impact on the systemic exposure of carboplatin. Paclitaxel exposure was decreased by an average of 18% in cycle 2 compared to cycle 1 for Pts treated with PTK/ZK 1250 mg/day. Conclusion: Combination of PTK/ZK with paclitaxel and carboplatin is feasible and shows favorable safety profile. The combination is active in EOC and deserves further evaluation. [Table: see text]
Collapse
Affiliation(s)
- W. Schroder
- Kinikum Bremen-Mitte gGmbH, Bremen, Germany; Centre René Gauducheau, St. Herblain, France; Centre Paul Papin, Angers, France; UMC Utrecht, Utrecht, The Netherlands; Institute Paoli Calmettes, Marseille, France; Schering OY, Helsinki, Finland; Novartis Pharmaceuticals, East Hanover, NJ; Schering AG, Berlin, Germany; HSK Dr. Horst Schmidt Hospital, Wiesbaden, Germany
| | - M. Campone
- Kinikum Bremen-Mitte gGmbH, Bremen, Germany; Centre René Gauducheau, St. Herblain, France; Centre Paul Papin, Angers, France; UMC Utrecht, Utrecht, The Netherlands; Institute Paoli Calmettes, Marseille, France; Schering OY, Helsinki, Finland; Novartis Pharmaceuticals, East Hanover, NJ; Schering AG, Berlin, Germany; HSK Dr. Horst Schmidt Hospital, Wiesbaden, Germany
| | - S. Abadie
- Kinikum Bremen-Mitte gGmbH, Bremen, Germany; Centre René Gauducheau, St. Herblain, France; Centre Paul Papin, Angers, France; UMC Utrecht, Utrecht, The Netherlands; Institute Paoli Calmettes, Marseille, France; Schering OY, Helsinki, Finland; Novartis Pharmaceuticals, East Hanover, NJ; Schering AG, Berlin, Germany; HSK Dr. Horst Schmidt Hospital, Wiesbaden, Germany
| | - P. Witteveen
- Kinikum Bremen-Mitte gGmbH, Bremen, Germany; Centre René Gauducheau, St. Herblain, France; Centre Paul Papin, Angers, France; UMC Utrecht, Utrecht, The Netherlands; Institute Paoli Calmettes, Marseille, France; Schering OY, Helsinki, Finland; Novartis Pharmaceuticals, East Hanover, NJ; Schering AG, Berlin, Germany; HSK Dr. Horst Schmidt Hospital, Wiesbaden, Germany
| | - P. Viens
- Kinikum Bremen-Mitte gGmbH, Bremen, Germany; Centre René Gauducheau, St. Herblain, France; Centre Paul Papin, Angers, France; UMC Utrecht, Utrecht, The Netherlands; Institute Paoli Calmettes, Marseille, France; Schering OY, Helsinki, Finland; Novartis Pharmaceuticals, East Hanover, NJ; Schering AG, Berlin, Germany; HSK Dr. Horst Schmidt Hospital, Wiesbaden, Germany
| | - T. Jalava
- Kinikum Bremen-Mitte gGmbH, Bremen, Germany; Centre René Gauducheau, St. Herblain, France; Centre Paul Papin, Angers, France; UMC Utrecht, Utrecht, The Netherlands; Institute Paoli Calmettes, Marseille, France; Schering OY, Helsinki, Finland; Novartis Pharmaceuticals, East Hanover, NJ; Schering AG, Berlin, Germany; HSK Dr. Horst Schmidt Hospital, Wiesbaden, Germany
| | - M. Palacay-Radona
- Kinikum Bremen-Mitte gGmbH, Bremen, Germany; Centre René Gauducheau, St. Herblain, France; Centre Paul Papin, Angers, France; UMC Utrecht, Utrecht, The Netherlands; Institute Paoli Calmettes, Marseille, France; Schering OY, Helsinki, Finland; Novartis Pharmaceuticals, East Hanover, NJ; Schering AG, Berlin, Germany; HSK Dr. Horst Schmidt Hospital, Wiesbaden, Germany
| | - S. Bilic
- Kinikum Bremen-Mitte gGmbH, Bremen, Germany; Centre René Gauducheau, St. Herblain, France; Centre Paul Papin, Angers, France; UMC Utrecht, Utrecht, The Netherlands; Institute Paoli Calmettes, Marseille, France; Schering OY, Helsinki, Finland; Novartis Pharmaceuticals, East Hanover, NJ; Schering AG, Berlin, Germany; HSK Dr. Horst Schmidt Hospital, Wiesbaden, Germany
| | - D. Laurent
- Kinikum Bremen-Mitte gGmbH, Bremen, Germany; Centre René Gauducheau, St. Herblain, France; Centre Paul Papin, Angers, France; UMC Utrecht, Utrecht, The Netherlands; Institute Paoli Calmettes, Marseille, France; Schering OY, Helsinki, Finland; Novartis Pharmaceuticals, East Hanover, NJ; Schering AG, Berlin, Germany; HSK Dr. Horst Schmidt Hospital, Wiesbaden, Germany
| | - A. Du Bois
- Kinikum Bremen-Mitte gGmbH, Bremen, Germany; Centre René Gauducheau, St. Herblain, France; Centre Paul Papin, Angers, France; UMC Utrecht, Utrecht, The Netherlands; Institute Paoli Calmettes, Marseille, France; Schering OY, Helsinki, Finland; Novartis Pharmaceuticals, East Hanover, NJ; Schering AG, Berlin, Germany; HSK Dr. Horst Schmidt Hospital, Wiesbaden, Germany
| |
Collapse
|
5
|
Schroder W, Witteveen E, Abadie S, Campone M, Viens P, Jalava T, Masson E, Chlistalla A, Du Bois A. A phase IB, open label, safety and pharmacokinetic (PK) study of escalating doses of PTK787/ZK 222584 in combination with paclitaxel and carboplatin in patients (PTs) with stage IIC to IV epithelial ovarian cancer. J Clin Oncol 2005. [DOI: 10.1200/jco.2005.23.16_suppl.5042] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Affiliation(s)
- W. Schroder
- Zentralkrankenhaus/Frauenklinik, Bremen, Germany; UMC Utrecht, Utrecht, The Netherlands; Ctr Paul Papin, Angers, France; Ctr Rene Gauducheau, Nantes, France; Inst Paoli Calmettes, Marseilles, France; Schering AG, Berlin, Germany; Novartis Pharm Corp., East Hanover, NJ; Dr. Horst Schmidt Klin, Wiesbaden, Germany
| | - E. Witteveen
- Zentralkrankenhaus/Frauenklinik, Bremen, Germany; UMC Utrecht, Utrecht, The Netherlands; Ctr Paul Papin, Angers, France; Ctr Rene Gauducheau, Nantes, France; Inst Paoli Calmettes, Marseilles, France; Schering AG, Berlin, Germany; Novartis Pharm Corp., East Hanover, NJ; Dr. Horst Schmidt Klin, Wiesbaden, Germany
| | - S. Abadie
- Zentralkrankenhaus/Frauenklinik, Bremen, Germany; UMC Utrecht, Utrecht, The Netherlands; Ctr Paul Papin, Angers, France; Ctr Rene Gauducheau, Nantes, France; Inst Paoli Calmettes, Marseilles, France; Schering AG, Berlin, Germany; Novartis Pharm Corp., East Hanover, NJ; Dr. Horst Schmidt Klin, Wiesbaden, Germany
| | - M. Campone
- Zentralkrankenhaus/Frauenklinik, Bremen, Germany; UMC Utrecht, Utrecht, The Netherlands; Ctr Paul Papin, Angers, France; Ctr Rene Gauducheau, Nantes, France; Inst Paoli Calmettes, Marseilles, France; Schering AG, Berlin, Germany; Novartis Pharm Corp., East Hanover, NJ; Dr. Horst Schmidt Klin, Wiesbaden, Germany
| | - P. Viens
- Zentralkrankenhaus/Frauenklinik, Bremen, Germany; UMC Utrecht, Utrecht, The Netherlands; Ctr Paul Papin, Angers, France; Ctr Rene Gauducheau, Nantes, France; Inst Paoli Calmettes, Marseilles, France; Schering AG, Berlin, Germany; Novartis Pharm Corp., East Hanover, NJ; Dr. Horst Schmidt Klin, Wiesbaden, Germany
| | - T. Jalava
- Zentralkrankenhaus/Frauenklinik, Bremen, Germany; UMC Utrecht, Utrecht, The Netherlands; Ctr Paul Papin, Angers, France; Ctr Rene Gauducheau, Nantes, France; Inst Paoli Calmettes, Marseilles, France; Schering AG, Berlin, Germany; Novartis Pharm Corp., East Hanover, NJ; Dr. Horst Schmidt Klin, Wiesbaden, Germany
| | - E. Masson
- Zentralkrankenhaus/Frauenklinik, Bremen, Germany; UMC Utrecht, Utrecht, The Netherlands; Ctr Paul Papin, Angers, France; Ctr Rene Gauducheau, Nantes, France; Inst Paoli Calmettes, Marseilles, France; Schering AG, Berlin, Germany; Novartis Pharm Corp., East Hanover, NJ; Dr. Horst Schmidt Klin, Wiesbaden, Germany
| | - A. Chlistalla
- Zentralkrankenhaus/Frauenklinik, Bremen, Germany; UMC Utrecht, Utrecht, The Netherlands; Ctr Paul Papin, Angers, France; Ctr Rene Gauducheau, Nantes, France; Inst Paoli Calmettes, Marseilles, France; Schering AG, Berlin, Germany; Novartis Pharm Corp., East Hanover, NJ; Dr. Horst Schmidt Klin, Wiesbaden, Germany
| | - A. Du Bois
- Zentralkrankenhaus/Frauenklinik, Bremen, Germany; UMC Utrecht, Utrecht, The Netherlands; Ctr Paul Papin, Angers, France; Ctr Rene Gauducheau, Nantes, France; Inst Paoli Calmettes, Marseilles, France; Schering AG, Berlin, Germany; Novartis Pharm Corp., East Hanover, NJ; Dr. Horst Schmidt Klin, Wiesbaden, Germany
| |
Collapse
|
6
|
|
7
|
Abstract
The role that Epstein-Barr virus plays in nasopharyngeal carcinoma and Burkitt's lymphoma has been under intense study for many years. With only a limited set of viral genes being expressed in these tumours it has been difficult to understand how the virus could cause/aid in the generation of the tumours. In 1997 a paper was published by Fries et al. [Fries et al. (1997) Identification of a novel protein encoded by the BamH1 A region of the Epstein-Barr virus. J Virol 71: 2765-2771.] in which a rabbit serum was generated and used to identify protein products (RK-BARF0) encoded from the BamH1 A region of EBV. In this paper we have isolated these proteins from two-dimensional gels and identified them, using mass spectrometry, as components of HLA DR.
Collapse
Affiliation(s)
- W Schroder
- The Queensland Institute of Medical Research, Brisbane, Australia
| | | | | | | |
Collapse
|
8
|
Schroder W, Burger M, Edwards C, Douglas M, Innes D, Beacham IR, Burns DM. The Escherichia coli orthologue of the Salmonella ushB gene (ushB(c)) produces neither UDP-sugar hydrolase activity nor detectable protein, but has an identical sequence to that of Escherichia coli cdh. FEMS Microbiol Lett 2001; 203:63-8. [PMID: 11557141 DOI: 10.1111/j.1574-6968.2001.tb10821.x] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022] Open
Abstract
Salmonella ushB, which encodes a membrane-bound UDP-sugar hydrolase, has an Escherichia coli orthologue (ushB(c)) which does not detectably produce this activity. In this report, we show that ushB(c) does not produce any detectable protein either, despite being transcribed normally. Remarkably, ushB(c) is shown to have 100% sequence identity with E. coli cdh, previously characterised as encoding an active CDP-diglyceride hydrolase, an apparent contradiction with implications regarding enzyme evolution. We suggest that a useful gene designation is cdh (ushB(c)) rather than either ushB(c) or cdh, alone.
Collapse
Affiliation(s)
- W Schroder
- School of Biomolecular and Biomedical Science, Griffith University, Nathan, Brisbane, Queensland 4111, Australia
| | | | | | | | | | | | | |
Collapse
|
9
|
Luck HJ, Du Bois A, Weber B, Pfisterer J, Goupil A, Kuhn W, Barats JC, Blohmer J, Mousseau M, Schroder W, Meier W, Mobus V, Richter B. The integration of anthracyclines in the treatment of advanced ovarian cancer. Int J Gynecol Cancer 2001. [DOI: 10.1046/j.1525-1438.11.s1.2.x] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
10
|
Chowdhury MR, Herrmann FH, Schroder W, Lambert CT, Lalloz MR, Layton M, Kumbnani HK, Kabra M, Menon PS, Verma IC. Factor VIII gene polymorphisms in the Asian Indian population. Haemophilia 2000; 6:625-30. [PMID: 11122386 DOI: 10.1046/j.1365-2516.2000.00442.x] [Citation(s) in RCA: 19] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
Little is known about the heterozygous frequency of factor VIII gene markers in the Asian Indian population. The objective of this study was to establish the heterozygous frequency of polymorphic markers within and flanking the factor VIII gene in Indians and identify those most informative for carrier screening and prenatal diagnosis. Factor VIII gene polymorphism analysis at intragenic and extragenic sites was carried out by the polymerase chain reaction (PCR) method and Southern blot procedure. Sixty-three Asian Indian haemophiliacs and their families were screened. A control group of 150 women from nonhaemophilic families were screened for two markers, HindIII and BclI. Among the intragenic markers studied, the HindIII restriction fragment length polymorphism (RFLP) showed the highest heterozygous frequency (0.52) followed by the intron 13 (0.47) and intron 22 (0. 44) short tandem repeats (STRs). Among extragenic markers, TaqI had the highest heterozygous frequency (0.75) followed by BglII (0.54). The intron 22 inversion mutation was observed in eight (40%) of 20 severe cases. In the population studied the most diagnostic polymorphisms were the intragenic markers, intron 22 (70%) STR followed by the intron 13 (52%) STR and HindIII (52%) RFLP, and the TaqI (50%) extragenic marker. Application of HindIII, BclI and the intron 22 dinucleotide repeat combined were diagnostic in 87.2% of haemophilia A families studied.
Collapse
Affiliation(s)
- M R Chowdhury
- Genetics Unit, Department of Paediatrics, All India Institute of Medical Sciences, New Delhi, India.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
11
|
Baum G, Kisker E, Raith W, Schroder W, Stillmen U, Zenses D. Spin-dependent electron impact ionisation of lithium from threshold to 80 eV. ACTA ACUST UNITED AC 1999. [DOI: 10.1088/0022-3700/14/22/020] [Citation(s) in RCA: 20] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
|
12
|
|
13
|
Abstract
Abstract:
Bicyclic acetals play an important role as volatile signals in systems of chemical communication among many insect species, i.e. bark beetles, weevils, and moths. They represent cryptic ketodiols with a glycol- and 1,3- diol-substructure. Alkylated members of four different systems are known, namely derivatives of 2,7-dioxabicyclo[2.2.1]heptane, 2,8-dioxabicyclo [3.2.1]octane, 6,8-dioxabicyclo[3.2.1]octane, and 2,9-dioxabicyclo[3.3.1]
nonane. Some of the compounds carry an additional oxygen function. A couple of structures have been extensively used as model compounds for studies in synthetic organic chemistry. Brevicomin, 7-ethyl-5-methyl-6,8-dioxabicyclo[3.2.1]octane as well as frontalin, 1,5-dimethyl-
6,8-dioxabicyclo[3.2.1]octane, have been most frequently prepared. Both pheromones are components of a kind of dialog between males and females of Dendroctonus bark beetles. Also, predators use them as kairomones. Frontalin and 1,3,3-trimethyl-2,7- dioxabicyclo[2.2.1]heptane have been found in volatiles of elephants and men, respectively, however, their biological significance is unknown in these cases. This review will provide an overview over structures of bicyclic acetals which are used as pheromones. It will comprise present knowledge on their occurrence and biological function and include facts and speculations concerning their biosynthesis. Furtheron, analytical aspects, especially mass spectrometry will be discussed, and plotted spectra will be shown. Syntheses, especially those providing optically active products carried out during the last eight years, will be reviewed.
Collapse
Affiliation(s)
- W. Francke
- lnstitut ftJr Organische Chemie, Universitat Hamburg, Martin-Luther-King-Piatz 6, D-20146 Hamburg, Germany
| | - W. Schroder
- lnstitut ftJr Organische Chemie, Universitat Hamburg, Martin-Luther-King-Piatz 6, D-20146 Hamburg, Germany
| |
Collapse
|
14
|
Beckmann M, An H, Niederacher D, Kohrer K, Finken-Eigen M, Schroder W, Schnurch H, Bender H. Oncogene amplification in archival ovarian carcinoma detected by fluorescent differential polymerase chain reaction - a routine analytical approach. Int J Gynecol Cancer 1996. [DOI: 10.1046/j.1525-1438.1996.06040291.x] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
15
|
Sieg F, Schroder W, Schmitt JM, Hincha DK. Purification and Characterization of a Cryoprotective Protein (Cryoprotectin) from the Leaves of Cold-Acclimated Cabbage. Plant Physiol 1996; 111:215-221. [PMID: 12226287 PMCID: PMC157828 DOI: 10.1104/pp.111.1.215] [Citation(s) in RCA: 21] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/20/2023]
Abstract
We have purified a protein (cryoprotectin) from the leaves of cold-acclimated cabbage (Brassica oleracea L.) that protects thylakoids from nonacclimated spinach (Spinacia oleracea L.) against freeze-thaw damage. The procedure involves precipitations by heat, ammonium sulfate, and the glycosaminoglycan heparin and column chromatography on Polyamide 6 and a C18 reverse-phase matrix. After reverse-phase chromatography we obtained a single band of an apparent molecular mass of 7 kD when fractions that showed cryoprotective activity were analyzed by sodium dodecyl sulfate gel electrophoresis and silver staining. Gel-filtration experiments confirmed that the active protein is a monomer of 7 kD native molecular mass. This 7-kD protein could be purified only from cold-acclimated cabbage, but not from plants grown under nonacclimating conditions. Using peroxidase-labeled lectins, we show that cryoprotectin is a glycoprotein and that the saccharide moiety contains [alpha]1-3-linked fucose.
Collapse
Affiliation(s)
- F. Sieg
- Institut fur Pflanzenphysiologie und Mikrobiologie, Freie Universitat, Konigin Luise-Strasse 12-16, D-14195 Berlin, Germany (F.S., J.M.S., D.K.H.)
| | | | | | | |
Collapse
|
16
|
Abstract
Increasing attention has been directed toward using magnetic resonance imaging (MRI) to assess blood flow velocity. Complete acceptance of this application requires validation of MRI-derived flow measurements against an accepted flow measurement technique such as Doppler ultrasound in an in vivo situation. To provide an accurate correlation in the presence of rapid changes in blood flow, the MR acquisition should be made nearly simultaneously with the ultrasonic measurements. Unfortunately, standard ultrasound equipment generates radio frequency signal which interferes with MRI. Near-simultaneous acquisition of MR data and ultrasonic blood flow data should be possible if the two measurements are properly synchronized. In the technique presented, ultrasound is made to peacefully coexist with MRI by gating the ultrasound so that it is disabled during the time of MR data acquisition. Phantom and animal experiments confirm the use of this procedure. Although we did not specifically test new fast-scan MR techniques, our technique is completely general and should work equally well with spin-echo as well as newer fast scanning MRI techniques.
Collapse
Affiliation(s)
- D A Sebok
- Laurie Imaging Center, Robert Wood Johnson School of Medicine New Brunswick, New Jersey 08901
| | | | | | | | | |
Collapse
|
17
|
Munoz E, Schroder W, Pace B, Mulloy K, Margolis I, Wise L. The identifier concept: clinical variables and patient costs for general surgical diagnosis-related groups. Curr Surg 1989; 46:91-6. [PMID: 2500304] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
|
18
|
Abstract
The objective of this study was to test the hypothesis that hospitalized patients referred to a general surgical service from a medical service for a surgical procedure would have higher hospital costs and longer lengths of stay per diagnosis-related group (DRG) than patients admitted directly to the general surgical service. Hospital costs by DRG, exclusive of physician's fees, were analyzed for all adult general surgical admissions treated at our hospital from January 1, 1985 to March 31, 1986 (3,028 patients) to yield a population of patients in those DRGs with patients referred to general surgery from medicine (1,495 patients). Patients within each DRG were then disaggregated by either direct admission to general surgery (1,412 patients) or referral to the general surgical service from the medical service (83 patients). Mean cost per patient was 146.5 percent higher for referral patients than for direct admission patients, as was the total length of stay. Mortality was higher for referral patients than for direct admission patients. Factors analyzed which contributed to this greater resource utilization and higher mortality were (1) a greater severity of illness, (2) higher diagnostic costs, and (3) delays in diagnosis or treatment. The DRG payment for referral patients also produced a substantial deficit for the hospital, whereas direct admission patients produced a profit of +1,105,596. This data suggests that direct admission to the surgical service of patients likely to need surgery might lower their hospital costs and improve the quality of their care.
Collapse
Affiliation(s)
- E Muñoz
- Department of Surgery, Long Island Jewish Medical Center, New Hyde Park, New York 11042
| | | | | | | | | | | |
Collapse
|
19
|
Kent MG, Shoffner RN, Hunter A, Elliston KO, Schroder W, Tolley E, Wachtel SS. XY sex reversal syndrome in the mare: clinical and behavioral studies, H-Y phenotype. Hum Genet 1988; 79:321-8. [PMID: 3410457 DOI: 10.1007/bf00282169] [Citation(s) in RCA: 17] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/05/2023]
Abstract
An inherited genetic disorder causes XY embryos of the horse to develop as mares. On the basis of our study of 38 such mares, we have identified four grades or classes of XY sex reversal according to this scheme: class I, nearly normal female, of which some are fertile; class II, female with gonadal dysgenesis, normal mullerian development; class III, intersex mare with gonadal dysgenesis, abnormal mullerian development, enlarged clitoris; class IV, virilized intersex characterized by high levels of testosterone. In general, class I and class II mares were typed H-Y antigen-negative whereas class III and class IV mares were typed H-Y antigen-positive.
Collapse
Affiliation(s)
- M G Kent
- Department of Obstetrics and Gynecology, University of Tennessee, Memphis 38163
| | | | | | | | | | | | | |
Collapse
|
20
|
Cohen JR, Schroder W, Leal J, Wise L. Mesenteric shunting during thoracoabdominal aortic clamping to prevent disseminated intravascular coagulation in dogs. Ann Vasc Surg 1988; 2:261-7. [PMID: 3191007 DOI: 10.1016/s0890-5096(07)60012-0] [Citation(s) in RCA: 31] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/04/2023]
Abstract
The current study was undertaken to determine if cold crystalloid perfusion of the mesenteric circulation or continuous arterial shunting into the superior mesenteric artery would prevent the subsequent development of disseminated intravascular coagulation in a dog model. Twenty-two dogs were divided into four groups: those with distal aortic occlusion; those with isolated washout of the mesenteric circulation via the superior mesenteric artery with cold crystalloid; those with continuous isolated arterial perfusion of the superior mesenteric artery via an open proximal aorta; and those with shunting of blood into the superior mesenteric artery from the proximal aorta with an Inahara-Pruitt shunt. Coagulation parameters were measured for 24 hours and compared to the results with 32 dogs in the following groups: sham operation; supraceliac aortic occlusion for 30 minutes, 60 minutes, 90 minutes; superior mesenteric occlusion for 90 minutes; and celiac axis occlusion for 90 minutes. Shunting or direct arterial perfusion of the superior mesenteric artery prevented disseminated intravascular coagulation from occurring. Infrarenal aortic occlusion resulted in no change in any of the coagulation factors, whereas crystalloid perfusion of the superior mesenteric artery resulted in death in all animals. These results indicate that the disseminated intravascular coagulation that occurs with supraceliac aortic occlusion or superior mesenteric occlusion of greater then one hour can be prevented by continuous arterial perfusion of the superior mesenteric artery during proximal aortic clamping.
Collapse
Affiliation(s)
- J R Cohen
- Department of Surgery, Long Island Jewish Medical Center, New Hyde Park, New York 11042
| | | | | | | |
Collapse
|
21
|
Affiliation(s)
- E Muñoz
- Division of Neurosurgery, Queens Hospital Center, Jamaica, New York
| | | | | | | | | | | |
Collapse
|
22
|
Abstract
The purpose of this study was to determine whether aortic elastase could be activated by distant operative trauma unrelated to direct aortic injury. One hundred rabbits were divided into five groups: group I - anesthesia only; group II - laparotomy only; group III - cecal resection; group IV - aortic mobilization; and group V - aortotomy with repair. Animals were sacrificed at one hour, three hours, six hours, one day, two days, and five days after surgery, and the aorta was analyzed for elastase activity. Operative trauma such as laparotomy, bowel resection, and mobilization of the aorta without direct aortic injury resulted in a significant increase in rabbit aortic elastase. The pattern of activation of rabbit aortic elastase within the laparotomy, aortic mobilization, and aortotomy groups was one of a slow rise to peak activation at 6-24 hours with a subsequent fall towards baseline at five days after surgery. This pattern differed in the cecal resection group in which activation occurred immediately with a slow fall towards baseline at five days. In none of the four surgical groups did the elastase activity return to baseline by five days after surgery. These data suggest that aortic elastase in rabbits can be activated by intraabdominal surgery unrelated to direct aortic injury.
Collapse
Affiliation(s)
- J R Cohen
- Department of Surgery, Long Island Jewish Medical Center, New Hyde Park, NY 11042
| | | | | | | |
Collapse
|
23
|
Muñoz E, Friedman R, Schroder W, Gross H, Goldstein J, Wise L. Age, resource consumption, and outcome for surgical patients at an academic medical center. Surgery 1988; 103:335-43. [PMID: 3125621] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/04/2023]
Abstract
Many changes are under way in the payment for physician and hospital care of the surgical patient. Relatively little data have been analyzed on resource consumption for hospitalized surgical patients. The purpose of this study was to characterize hospital resource consumption and outcome by age for surgical patients. All surgical admissions at a large academic medical center from Jan. 1, 1985, through March 31, 1986, were analyzed by means of the diagnostic related group (DRG) format. Total costs (exclusive of physician fees) for the 7341 surgical patients studied were $58,206,815. Mean cost per patient, length of stay, percent of outliers, and mortality increased with age. DRG case-mix index and the number of procedures per patient peaked at age 69 and then decreased. Emergency admission was high for the young (i.e., aged 18 to 24 years) and for very elderly patients (i.e., aged over 75 years). Blood transfusions increased steadily as the age of the patient increased; use of surgical intensive care units increased until age 64 years, then plateaued. This study demonstrated a number of trends in surgical patient age and use of resources. Under prospective payment systems (i.e., DRG reimbursement) financial risk increased with the age of the patient. Length of hospital stay and mortality increased with age; however, DRG case-mix index and the number of procedures per patient peaked at age 69, which suggests that elderly surgical patients (i.e., those above 70 years of age) may be more severely ill on average than younger patients.
Collapse
Affiliation(s)
- E Muñoz
- Department of Surgery, Long Island Jewish Medical Center, New Hyde Park, NY 11042
| | | | | | | | | | | |
Collapse
|
24
|
Geist V, Knaus W, Schroder W. Das Gamswild. J Wildl Manage 1977. [DOI: 10.2307/3800110] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
|
25
|
Schroder W. INQUEST FEES TO HOSPITAL OFFICERS. West J Med 1905. [DOI: 10.1136/bmj.1.2308.693-a] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
26
|
Schroder W. INQUEST FEES TO HOSPITAL OFFICERS. West J Med 1905. [DOI: 10.1136/bmj.1.2305.512] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|